Axcella Health Inc. Gains 29.57%

Fri, Sep 16, 2022 at 07:21 PM

Axcella Health Inc. (AXLA:NASDAQ) soared at $2.41, a gain of 29.6%. On Fri, Sep 16, 2022, AXLA:NASDAQ hit a New 2-Week High of $2.41. The stock got featured on our News Catalysts scanner on Mon, Sep 12, 2022 at 08:58 AM in the 'MISCELLANEOUS' category. From Fri, Sep 02, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days

About Axcella Health Inc. (AXLA:NASDAQ)

Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. The company's pipeline comprises of five programs focused on the metabolic functions of the liver, muscle and blood.

Top 10 Gainers:

Panbela Therapeutics Inc. (PBLA:NASDAQ), 53.03%
Applied Optoelectronics, Inc. (AAOI:NASDAQ), 50.4%
iBio, Inc. (IBIO:NYSEMKT), 49.84%
Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 31.15%
Axcella Health Inc. (AXLA:NASDAQ), 29.57%
Anixa Biosciences, Inc. (ANIX:NASDAQ), 27.46%
Lannett Company, Inc. (LCI:NYSE), 25.1%
Integrated Media Technology Limited (IMTE:NASDAQ), 21.53%
Innate Pharma S.A. (IPHA:NASDAQ), 20.87%
TMC the metals company Inc. (TMC:NASDAQ), 20.19%